Scotland approves three new medicines
July 13, 2021Manufacturing and Production
The SMC has approved three new medicines; atezolizumab to treat adult patients with advanced hepatocellular carcinoma (HCC, a type of …
Biogen announces collaboration on novel MS treatment
July 13, 2021Manufacturing and Production multiple sclerosis
Biogen and InnoCare Pharma have announced a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase …
WHO official condemns lack of masks at Euro finals
July 12, 2021Sales and Marketing
WHO COVID-19 technical lead, Maria Van Kerkhove, has condemned the lack of masks and social distancing at last night’s Euro …
Long COVID: Test may be available within six months
July 12, 2021Sales and Marketing
Researchers from Imperial College London have detected rogue antibodies in the blood of long COVID sufferers, which could lead to …
Janssen & Vor Biopharma to collaborate on acute myeloid leukemia treatment
July 12, 2021Sales and Marketing
Vor Biopharma and Janssen have announced a collaboration to develop engineered hematopoietic stem cell transplants combined with a bi-specific antibody …
FDA acting commissioner seeks review of controversial Alzheimer’s drug approval
July 12, 2021Sales and Marketing
The FDA’s acting commissioner Janet Woodcock is asking for a federal investigation of doctors within her own agency who met …
New data demonstrates extensive activity of Shionogi’s antibiotic cefiderocol
July 12, 2021Sales and Marketing
Shionogi’s novel antibiotic, cefiderocol, has extensive in vitro activity against some of the most difficult to treat carbapenem-resistant Gram-negative bacteria.The …
NICE rejects gene therapy for children with neurodegenerative disorder
July 9, 2021Medical Communications
NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …
FDA narrows guidance on controversial Alzheimer’s drug
July 9, 2021Medical Communications
A month after the approval of Biogen’s controversial new Alzheimer’s drug, Aduhelm, the FDA has narrowed its guidance on who …
Global genetic exome sequence analysis collaboration announced
July 9, 2021Medical Communications
AbbVie, Pfizer, and Biogen have announced the launch of the world’s largest browsable resource linking rare protein-coding genetic variants to …
Tech successful in harvesting cancer cells in brain metastases patients
July 9, 2021Medical Communications
The University Medical Centre Hamburg-Eppendorf has published results of new work undertaken in patients with brain metastasis using ANGLE’s cell …
Children “extremely low risk” from COVID study finds
July 9, 2021Medical Communications COVID-19, Vaccine
The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …
The pill to be sold over the counter for first time in UK history
July 8, 2021The contraceptive pill will be sold over the counter without prescription for the first time in UK history. The MHRA …
Exscientia receives $1.5 million Gates grant for Covid-19 therapy
July 8, 2021The Oxford-based drugs firm Exscientia has won a $1.5 million grant from the Bill & Melinda Gates Foundation to create …
Gyros Protein Technologies and Cygnus Technologies expand collaboration
July 8, 2021Gyros Protein has announced the next phase of its on-going collaboration with Cygnus Technologies alongside the introduction of a new …
New screening method set to speed up drug discovery in major diseases
July 8, 2021drug discovery
Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …
WHO recommends Roche and Sanofi treatments to cut COVID-19 death risk
July 8, 2021The WHO has recommended using arthritis drugs Actemra from Roche and Kevzara from Sanofi with corticosteroids for COVID-19 patients. This …
Mass COVID testing reduces cases by a fifth study shows
July 7, 2021Research and Development COVID-19 testing, COVID-19. testing, lateral flow tests, liverpool
A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …
First ex vivo human skin platform investigating ISR launched
July 7, 2021Research and Development
Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …
Summer COVID cases set to reach 2 million with 10 million isolating
July 7, 2021Research and Development COVID-19, Lockdown, UK, Vaccine, government
Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
